Tadalafil( TAD)and dapoxetine HCl( DAP)are recently co-formulated and both show native fluo-rescence. Therefore,a novel,accurate,specific and sensitive reversed-phase high performance liquid chroma-tographic method with fluorescence detection was developed and validated for their separation and quantitation in dosage form and human plasma using avanafil as an internal standard( IS). Separation was achieved using isocratic elution within 7. 0 min on C18 column and acetonitrile-0. 15% triethylamine( 40∶60,v/v;pH 4)as a mobile phase. The flow rate was 1. 0 mL/min and the detection was time-programmed at 330,410 and 370 nm for TAD,DAP and IS,respectively,after excitation at 236 nm. The linear ranges from 0. 01 to 30. 00 μg/mL for each drug with the limits of detection of 4. 20 and 7. 20 ng/mL for TAD and DAP,respectively. The method was validated in accordance to the International Conference on Harmonization( ICH)guidelines and was successful-ly applied to spiked human plasma with mean recoveries of 98. 17% and 98. 83% for TAD and DAP respectively.
参考文献
| [1] | Maryadele J;Neil O.The Merck Index:An Encyclopedia of Chemicals,Drugs and Biologicals[M].Whitehouse Station:Di-vision of Merck and Co,2006 |
| [2] | Sweetman S C.Martindale:The Complete Drug Reference[M].London:Pharmaceutical Press,2007 |
| [3] | Wright PJ.Comparison of phosphodiesterase type 5 (PDE5) inhibitors.[J].International journal of clinical practice,20068(8):967-975. |
| [4] | Brock G B;McMahon C G;Chen K K.[J].Journal Of Urology,2002168:1332. |
| [5] | Carson CC;Rajfer J;Eardley I;Carrier S;Denne JS;Walker DJ;Shen W;Cordell WH.The efficacy and safety of tadalafil: an update.[J].BJU international,20049(9):1276-1281. |
| [6] | Lewis R W;Sadovsky R;Eardley I.[J].JOURNAL OF SEXUAL MEDICINE,20052(4):517. |
| [7] | Gupta M;Kovar A;Meibohm B.The clinical pharmacokinetics of phosphodiesterase-5 inhibitors for erectile dysfunction.[J].The Journal of Clinical Pharmacology: Official Journal of the American College of Clinical Pharmacology,20059(9):987-1003. |
| [8] | Gengo P J;Giuliano F;McKenna K.[J].Journal Of Urology,2005173(4):239. |
| [9] | Kendirci M;Salem E;Hellstrom W J.[J].Ther Clin Risk Manag,20073(2):277. |
| [10] | Hiemke C;Hartter S.Pharmacokinetics of selective serotonin reuptake inhibitors.[J].Pharmacology and Therapeutics: The Journal of the International Encyclopedia of Pharmacology and Therapeutics,20001(1):11-28. |
| [11] | Modi NB;Dresser MJ;Simon M;Lin D;Desai D;Gupta S.Single- and multiple-dose pharmacokinetics of dapoxetine hydrochloride, a novel agent for the treatment of premature ejaculation.[J].The Journal of Clinical Pharmacology: Official Journal of the American College of Clinical Pharmacology,20063(3):301-309. |
| [12] | Pryor JL;Althof SE;Steidle C;Rosen RC;Hellstrom WJ;Shabsigh R;Miloslavsky M;Kell S.Efficacy and tolerability of dapoxetine in treatment of premature ejaculation: an integrated analysis of two double-blind, randomised controlled trials.[J].The Lancet,20069539(9539):929-937. |
| [13] | Buvat J;Tesfaye F;Rothman M.[J].EUROPEAN UROLOGY,200955(4):957. |
| [14] | Dresser MJ;Desai D;Gidwani S;Seftel AD;Modi NB.Dapoxetine, a novel treatment for premature ejaculation, does not have pharmacokinetic interactions with phosphodiesterase-5 inhibitors.[J].International journal of impotence research,20061(1):104-110. |
| [15] | Giri A D;Bhusari V K;Dhaneshwar S R.[J].Int J Pharm Pharm Sci,20124(2):654. |
| [16] | Rajeshwari M;Chenthilnathan A;Rama K.[J].Int J Pharm Bi-ol Sci,20144(2):72. |
| [17] | Rajpara C S;Akhtar J;Khandhar A .PharmaTutor,PHAR-MATUTOR-ART-1387[R].,1387. |
| [18] | Kavitha A;Vijaya D D;Hima B S.[J].Asian J Pharm Clin Res,20136(3):326. |
| [19] | Hamilton C L;Cornpropst J D.[J].Journal of Chromatography B,1993612(2):253. |
| [20] | I. C. H.Q2(R1)Guideline[A].Geneva,Switzerland,2005 |
| [21] | Singh S;Prasad B;Savaliya AA;Shah RP;Gohil VM;Kaur A.Strategies for characterizing sildenafil, vardenafil, tadalafil and their analogues in herbal dietary supplements, and detecting counterfeit products containing these drugs[J].TrAC: Trends in Analytical Chemistry,20091(1):13-28. |
| [22] | Pimple S;Shah M;Joshi A.[J].Int J Pharm Sci Rev Res,201426(2):328. |
| [23] | Forgue S T;Patterson B E;Bedding A W.[J].British Journal of Clinical Pharmacology(England),200561(3):280. |
| [24] | Dresser MJ;Kang D;Staehr P;Gidwani S;Guo C;Mulhall JP;Modi NB.Pharmacokinetics of dapoxetine, a new treatment for premature ejaculation: Impact of age and effects of a high-fat meal.[J].The Journal of Clinical Pharmacology: Official Journal of the American College of Clinical Pharmacology,20069(9):1023-1029. |
- 下载量()
- 访问量()
- 您的评分：
-
10%
-
20%
-
30%
-
40%
-
50%